151 related articles for article (PubMed ID: 31814686)
1. Medical expenditures for colorectal cancer diagnosis and treatment: A 10-year high-level-hospital-based multicenter retrospective survey in China, 2002
Shi J; Liu G; Wang H; Mao A; Liu C; Guo L; Huang H; Ren J; Liao X; Bai Y; Sun X; Zhu X; Wang J; Song B; Zhou J; Zhu L; Lei H; Liu Y; Liu Y; Du L; He Y; Zhang K; Li N; Chen W; Dai M; He J
Chin J Cancer Res; 2019 Oct; 31(5):825-837. PubMed ID: 31814686
[TBL] [Abstract][Full Text] [Related]
2. Expenditure and financial burden for the diagnosis and treatment of colorectal cancer in China: a hospital-based, multicenter, cross-sectional survey.
Huang HY; Shi JF; Guo LW; Bai YN; Liao XZ; Liu GX; Mao AY; Ren JS; Sun XJ; Zhu XY; Wang L; Song BB; Du LB; Zhu L; Gong JY; Zhou Q; Liu YQ; Cao R; Mai L; Lan L; Sun XH; Ren Y; Zhou JY; Wang YZ; Qi X; Lou PA; Shi D; Li N; Zhang K; He J; Dai M
Chin J Cancer; 2017 Apr; 36(1):41. PubMed ID: 28454595
[TBL] [Abstract][Full Text] [Related]
3. Medical expenditure for esophageal cancer in China: a 10-year multicenter retrospective survey (2002-2011).
Guo LW; Huang HY; Shi JF; Lv LH; Bai YN; Mao AY; Liao XZ; Liu GX; Ren JS; Sun XJ; Zhu XY; Zhou JY; Gong JY; Zhou Q; Zhu L; Liu YQ; Song BB; Du LB; Xing XJ; Lou PA; Sun XH; Qi X; Wu SL; Cao R; Lan L; Ren Y; Zhang K; He J; Zhang JG; Dai M;
Chin J Cancer; 2017 Sep; 36(1):73. PubMed ID: 28882179
[TBL] [Abstract][Full Text] [Related]
4. No expenditure difference among patients with liver cancer at stage I
Lei H; Lei L; Shi J; Wu Y; Liang L; Huang H; He M; Bai F; Cao M; Qiu H; Wang Y; Liu C; Du J; Wang H; Zhang Y; Cao M; Peng J; Li N; Qu C; Dai M; Chen W; He J
Chin J Cancer Res; 2020 Aug; 32(4):516-529. PubMed ID: 32963464
[TBL] [Abstract][Full Text] [Related]
5. Out-of-pocket medical expenditure and associated factors of advanced colorectal cancer in China: a multi-center cross-sectional study.
Wang H; Ma L; Gu XF; Li L; Wang WJ; Du LB; Xu HF; Cao HL; Zhang X; Shi JH; Zhao YQ; Liu YY; Huang JX; Cao J; Fan YP; Feng CY; Zhu Q; Du JC; Wang XH; Zhang SK; Qiao YL;
Ann Transl Med; 2022 Mar; 10(6):356. PubMed ID: 35433986
[TBL] [Abstract][Full Text] [Related]
6. Medical expenditure for liver cancer in urban China: A 10-year multicenter retrospective survey (2002-2011).
Qiu WQ; Shi JF; Guo LW; Mao AY; Huang HY; Hu GY; Dong P; Bai FZ; Yan XL; Liao XZ; Liu GX; Bai YN; Ren JS; Sun XJ; Zhu XY; Zhou JY; Gong JY; Zhu L; Mai L; Du LB; Zhou Q; Xing XJ; Song BB; Liu YQ; Lou PA; Sun XH; Wu SL; Cao R; Qi X; Lan L; Ren Y; Zhang K; He J; Qu C; Dai M
J Cancer Res Ther; 2018 Jan; 14(1):163-170. PubMed ID: 29516981
[TBL] [Abstract][Full Text] [Related]
7. Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study.
Zhang K; Yin J; Huang H; Wang L; Guo L; Shi J; Dai M
Front Public Health; 2020; 8():310. PubMed ID: 32850573
[No Abstract] [Full Text] [Related]
8. Clinical characteristics, medical service utilization, and expenditure for colorectal cancer in China, 2005 to 2014: Overall design and results from a multicenter retrospective epidemiologic survey.
Shi JF; Wang L; Ran JC; Wang H; Liu CC; Zhang HZ; Yang L; Shi SS; Jiang LM; Fan JH; Zhang YM; Wang WH; Ren JS; Zhu L; Zheng ZX; Sun YK; Zou SM; Jiang J; Chen B; Chen HD; Liu GX; Yang L; Huang YC; Guo LW; Wang DB; Zhang YZ; Mao AY; Wang JL; Gong JY; Wei DH; Qiu WQ; Song BB; Zhang K; Li N; Feletto E; Lew JB; Qiao YL; Chen WQ; Dai M; He J
Cancer; 2021 Jun; 127(11):1880-1893. PubMed ID: 33784413
[TBL] [Abstract][Full Text] [Related]
9. The effect of different classification of hospitals on medical expenditure from perspective of classification of hospitals framework: evidence from China.
Li L; Du T; Hu Y
Cost Eff Resour Alloc; 2020; 18():35. PubMed ID: 32944007
[TBL] [Abstract][Full Text] [Related]
10. In-patient Expenditure Between 2012 and 2020 Concerning Patients With Liver Cirrhosis in Chongqing: A Hospital-Based Multicenter Retrospective Study.
Tan J; Tang X; He Y; Xu X; Qiu D; Chen J; Zhang Q; Zhang L
Front Public Health; 2022; 10():780704. PubMed ID: 35350474
[TBL] [Abstract][Full Text] [Related]
11. [Economic burden of cancer in China during 1996-2014: a systematic review].
Shi JF; Shi CL; Yue XP; Huang HY; Wang L; Li J; Lou PA; Mao AY; Dai M
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):929-941. PubMed ID: 27998471
[No Abstract] [Full Text] [Related]
12. [Survey of economic burden of hepatitis B-related diseases in 12 areas in China].
Ma QS; Liang S; Xiao HW; Zhang SX; Zhuang GH; Zou YH; Tan HZ; Liu JC; Zhang YH; Xu AQ; Zhang L; Feng XX; Hu DS; Wang FZ; Cui FQ; Liang XF
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jul; 38(7):868-876. PubMed ID: 28738457
[No Abstract] [Full Text] [Related]
13. Estimating the economic burden of colorectal cancer in China, 2019-2030: A population-level prevalence-based analysis.
Wang H; Li YJ; Lei L; Liu CC; Chen WQ; Dai M; Wang X; Lew JB; Shi JF; Li N; He J
Cancer Med; 2023 Dec; 13(1):. PubMed ID: 38112048
[TBL] [Abstract][Full Text] [Related]
14. Medical expenses of urban Chinese patients with stomach cancer during 2002-2011: a hospital-based multicenter retrospective study.
Sun XJ; Shi JF; Guo LW; Huang HY; Yao NL; Gong JY; Sun YW; Liu GX; Mao AY; Liao XZ; Bai YN; Ren JS; Zhu XY; Zhou JY; Mai L; Song BB; Liu YQ; Zhu L; Du LB; Zhou Q; Xing XJ; Lou PA; Sun XH; Qi X; Wang Y; Cao R; Ren Y; Lan L; Zhang K; He J; Wang JL; Dai M;
BMC Cancer; 2018 Apr; 18(1):435. PubMed ID: 29665788
[TBL] [Abstract][Full Text] [Related]
15. [Priority setting in scaled-up cancer screening in China: an systematic review of economic evaluation evidences].
Shi JF; Mao AY; Bai YN; Liu GX; Liu CC; Wang H; Cao MM; Feng H; Wang L; Bai FZ; Huang HY; Bai HJ; Zhu J; Yan XX; Zhang J; Ren JS; Li N; Dai M; Chen WQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Mar; 54(3):306-313. PubMed ID: 32187937
[No Abstract] [Full Text] [Related]
16. Economic burden of dengue fever in China: A retrospective research study.
Xu M; Chang N; Tu T; Sun J; Jiang J; Xia Y; Tang W; Ji H; Zhao X; Zhu J; Qi L; Liu X; Liu Q
PLoS Negl Trop Dis; 2022 May; 16(5):e0010360. PubMed ID: 35594296
[TBL] [Abstract][Full Text] [Related]
17. Impacts of the zero mark-up drug policy on hospitalization expenses of COPD inpatients in Sichuan province, western China: an interrupted time series analysis.
Wang J; Li P; Wen J
BMC Health Serv Res; 2020 Jun; 20(1):519. PubMed ID: 32513170
[TBL] [Abstract][Full Text] [Related]
18. Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey.
Zhang X; Shi JF; Liu GX; Ren JS; Guo LW; Huang WD; Shi LM; Ma Y; Huang HY; Bai YN; Liao XZ; Mao AY; Sun XJ; Zhu XY; Zhou Q; Gong JY; Zhou JY; Liu YQ; Mai L; Song BB; Zhu L; Xing XJ; Du LB; Qi X; Sun XH; Wu SL; Ren Y; Cao R; Lan L; Lou PA; Zhang K; He J; Dai M
Cost Eff Resour Alloc; 2021 Aug; 19(1):53. PubMed ID: 34404418
[TBL] [Abstract][Full Text] [Related]
19. Knowledge and awareness of colorectal cancer risk factors, screening, and associated factors in advanced colorectal cancer patients: a multicenter cross-sectional study in China.
Xu HF; Gu XF; Wang XH; Wang WJ; Du LB; Duan SX; Liu Y; Zhang X; Zhao YQ; Ma L; Liu YY; Huang JX; Cao J; Fan YP; Li L; Feng CY; Lian XM; Du JC; Zhang JG; Yu YQ; Qiao YL;
Ann Transl Med; 2022 Mar; 10(6):354. PubMed ID: 35433933
[TBL] [Abstract][Full Text] [Related]
20. [Trend in medical expenditures for patients with kidney diseases: An analysis from a tertiary hospital in Beijing].
Bi SH; Li ZF; Wang T; Wang Y; Zhang C; Ji H; Shi J
Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Nov; 53(1):215-219. PubMed ID: 33550360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
